(BWIN) The Baldwin Insurance - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05589G1022

Personal, Commercial, Life, Health, Medicare

BWIN EPS (Earnings per Share)

EPS (Earnings per Share) of BWIN over the last years for every Quarter: "2020-09": -0.0987, "2020-12": -0.2901, "2021-03": 0.3302, "2021-06": -0.2184, "2021-09": -0.2763, "2021-12": -0.4127, "2022-03": 0.3895, "2022-06": 0.1444, "2022-09": -0.4328, "2022-12": -0.8361, "2023-03": -0.2407, "2023-06": -0.3977, "2023-09": 0.29, "2023-12": 0.14, "2024-03": 0.56, "2024-06": 0.34, "2024-09": -0.1309, "2024-12": -0.3112, "2025-03": 0.65, "2025-06": 0.42,

BWIN Revenue

Revenue of BWIN over the last years for every Quarter: 2020-09: null, 2020-12: null, 2021-03: null, 2021-06: null, 2021-09: null, 2021-12: 159.2, 2022-03: 242.848, 2022-06: 232.46, 2022-09: 259.368, 2022-12: 246.044, 2023-03: 330.446, 2023-06: 297.191, 2023-09: 306.27, 2023-12: 284.648, 2024-03: 380.367, 2024-06: 339.84, 2024-09: 336.043, 2024-12: 323.436, 2025-03: 408.529, 2025-06: 374.312,

Description: BWIN The Baldwin Insurance August 05, 2025

The Baldwin Insurance Group, Inc. (NASDAQ:BWIN) is a US-based independent insurance distribution firm that provides a range of insurance and risk management solutions through three distinct segments: Insurance Advisory Solutions, Underwriting, Capacity & Technology Solutions, and Mainstreet Insurance Solutions. The companys diverse offerings cater to businesses, high-net-worth individuals, and communities, providing private risk management, commercial risk management, employee benefits, and Medicare insurance solutions, among others.

From a business perspective, Baldwin Insurance Groups revenue streams are likely driven by commissions from insurance policy sales, consulting services, and technology-enabled insurance products. Key performance indicators (KPIs) to watch include revenue growth, segment-wise revenue contribution, and customer acquisition costs. The companys ability to leverage its MGA platform and technology-enabled insurance products will be crucial in driving growth and profitability.

To evaluate the companys financial health, we can look at metrics such as debt-to-equity ratio, interest coverage ratio, and operating cash flow margin. Given the negative RoE (-5.38%), it is essential to analyze the companys return on assets (ROA) and the efficiency of its asset utilization. Additionally, the forward P/E ratio of 20.37 suggests that investors have certain growth expectations, which need to be scrutinized in the context of the companys historical performance and industry benchmarks.

From a growth perspective, it is crucial to monitor the companys ability to expand its customer base, increase its market share, and drive innovation through its technology-enabled insurance products. The companys presence in the US insurance market, its competitive positioning, and the overall industry trends will also be essential in determining its growth prospects. Key metrics to track include the companys top-line growth, EBITDA margin, and the effectiveness of its distribution channels.

BWIN Stock Overview

Market Cap in USD 1,650m
Sub-Industry Insurance Brokers
IPO / Inception 2019-10-24

BWIN Stock Ratings

Growth Rating -36.9%
Fundamental 45.5%
Dividend Rating -
Return 12m vs S&P 500 -60.5%
Analyst Rating 3.75 of 5

BWIN Dividends

Currently no dividends paid

BWIN Growth Ratios

Growth Correlation 3m -91.6%
Growth Correlation 12m -73.7%
Growth Correlation 5y 33.1%
CAGR 5y -6.64%
CAGR/Max DD 3y (Calmar Ratio) -0.11
CAGR/Mean DD 3y (Pain Ratio) -0.32
Sharpe Ratio 12m -0.90
Alpha -80.55
Beta 1.391
Volatility 49.05%
Current Volume 850.5k
Average Volume 20d 881.2k
Stop Loss 20.7 (-6.3%)
Signal -0.45

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income (-17.8m TTM) > 0 and > 6% of Revenue (6% = 86.5m TTM)
FCFTA -0.03 (>2.0%) and ΔFCFTA -4.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 16.10% (prev -1.45%; Δ 17.55pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA -0.02 (>3.0%) and CFO -62.2m <= Net Income -17.8m (YES >=105%, WARN >=100%)
Net Debt (1.60b) to EBITDA (188.4m) ratio: 8.49 <= 3.0 (WARN <= 3.5)
Current Ratio 1.23 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (68.0m) change vs 12m ago 7.74% (target <= -2.0% for YES)
Gross Margin 26.61% (prev 18.90%; Δ 7.71pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 38.88% (prev 35.63%; Δ 3.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 2.45 (EBITDA TTM 188.4m / Interest Expense TTM 31.3m) >= 6 (WARN >= 3)

Altman Z'' 0.29

(A) 0.06 = (Total Current Assets 1.24b - Total Current Liabilities 1.01b) / Total Assets 3.74b
(B) -0.05 = Retained Earnings (Balance) -200.6m / Total Assets 3.74b
(C) 0.02 = EBIT TTM 76.8m / Avg Total Assets 3.71b
(D) -0.07 = Book Value of Equity -199.9m / Total Liabilities 2.69b
Total Rating: 0.29 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 45.49

1. Piotroski 2.0pt = -3.0
2. FCF Yield -3.23% = -1.61
3. FCF Margin -7.27% = -2.72
4. Debt/Equity 2.70 = -0.32
5. Debt/Ebitda 8.49 = -2.50
6. ROIC - WACC (= -2.51)% = -3.14
7. RoE -2.93% = -0.49
8. Rev. Trend 79.94% = 6.00
9. EPS Trend 65.64% = 3.28

What is the price of BWIN shares?

As of November 03, 2025, the stock is trading at USD 22.10 with a total of 850,525 shares traded.
Over the past week, the price has changed by -7.92%, over one month by -20.67%, over three months by -38.63% and over the past year by -52.13%.

Is The Baldwin Insurance a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, The Baldwin Insurance (NASDAQ:BWIN) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 45.49 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BWIN is around 16.14 USD . This means that BWIN is currently overvalued and has a potential downside of -26.97%.

Is BWIN a buy, sell or hold?

The Baldwin Insurance has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold BWIN.
  • Strong Buy: 3
  • Buy: 2
  • Hold: 2
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the BWIN price?

Issuer Target Up/Down from current
Wallstreet Target Price 38 71.9%
Analysts Target Price 38 71.9%
ValueRay Target Price 17.7 -20%

BWIN Fundamental Data Overview October 20, 2025

Market Cap USD = 1.65b (1.65b USD * 1.0 USD.USD)
P/E Forward = 13.21
P/S = 1.129
P/B = 3.1497
Beta = 1.391
Revenue TTM = 1.44b USD
EBIT TTM = 76.8m USD
EBITDA TTM = 188.4m USD
Long Term Debt = 1.61b USD (from longTermDebt, last quarter)
Short Term Debt = 33.4m USD (from shortTermDebt, last quarter)
Debt = 1.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.60b USD (from netDebt column, last quarter)
Enterprise Value = 3.25b USD (1.65b + Debt 1.70b - CCE 105.7m)
Interest Coverage Ratio = 2.45 (Ebit TTM 76.8m / Interest Expense TTM 31.3m)
FCF Yield = -3.23% (FCF TTM -104.8m / Enterprise Value 3.25b)
FCF Margin = -7.27% (FCF TTM -104.8m / Revenue TTM 1.44b)
Net Margin = -1.23% (Net Income TTM -17.8m / Revenue TTM 1.44b)
Gross Margin = 26.61% ((Revenue TTM 1.44b - Cost of Revenue TTM 1.06b) / Revenue TTM)
Gross Margin QoQ = 28.12% (prev 35.42%)
Tobins Q-Ratio = 0.87 (Enterprise Value 3.25b / Total Assets 3.74b)
Interest Expense / Debt = 1.84% (Interest Expense 31.3m / Debt 1.70b)
Taxrate = -15.37% (negative due to tax credits) (685.0k / -4.46m)
NOPAT = 88.6m (EBIT 76.8m * (1 - -15.37%)) [negative tax rate / tax credits]
Current Ratio = 1.23 (Total Current Assets 1.24b / Total Current Liabilities 1.01b)
Debt / Equity = 2.70 (Debt 1.70b / totalStockholderEquity, last quarter 630.8m)
Debt / EBITDA = 8.49 (Net Debt 1.60b / EBITDA 188.4m)
Debt / FCF = -15.25 (negative FCF - burning cash) (Net Debt 1.60b / FCF TTM -104.8m)
Total Stockholder Equity = 607.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.48% (Net Income -17.8m / Total Assets 3.74b)
RoE = -2.93% (Net Income TTM -17.8m / Total Stockholder Equity 607.3m)
RoCE = 3.47% (EBIT 76.8m / Capital Employed (Equity 607.3m + L.T.Debt 1.61b))
RoIC = 4.04% (NOPAT 88.6m / Invested Capital 2.19b)
WACC = 6.56% (E(1.65b)/V(3.35b) * Re(11.14%) + D(1.70b)/V(3.35b) * Rd(1.84%) * (1-Tc(-0.15)))
Discount Rate = 11.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.46%
Fair Price DCF = unknown (Cash Flow -104.8m)
EPS Correlation: 65.64 | EPS CAGR: 47.97% | SUE: 0.02 | # QB: 0
Revenue Correlation: 79.94 | Revenue CAGR: 14.27% | SUE: N/A | # QB: 0

Additional Sources for BWIN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle